PRINSTON INC FDA Approval ANDA 207188

ANDA 207188

PRINSTON INC

FDA Drug Application

Application #207188

Documents

Letter2017-09-07

Application Sponsors

ANDA 207188PRINSTON INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORALEQ 7.5MG BASE0PAROXETINE MESYLATEPAROXETINE MESYLATE

FDA Submissions

UNKNOWN; ORIG1AP2017-08-18STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207188
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PAROXETINE MESYLATE","activeIngredients":"PAROXETINE MESYLATE","strength":"EQ 7.5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/18\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/207188Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-08-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.